Hong Kong's capital market is welcoming a new round of IPO boom. Data shows that the total amount of funds raised by Hong Kong stocks IPOs in the past year reached HK$145 billion, a 2.7-fold increase year-on-year. CATL and Midea Group led the way in fundraising, and the top ten IPOs in terms of initial fundraising were mostly from the mainland, contributing a total of 75% of the financing scale. The reporter noted that the "A+H" dual capital market platform has become a key springboard for the global layout of leading companies. Hengrui Medicine is about to be listed, followed by industry chain giants such as Sanhua Intelligent Control and Lens Technology. Behind the market heat is the repricing of Chinese assets by international capital. The continued strengthening of the Hong Kong dollar exchange rate triggered the Hong Kong Monetary Authority's 100 billion injection of funds, and the influx of southbound funds accelerated, while the "money-making effect" of benchmark companies such as CATL formed a strong demonstration. Industry insiders pointed out that in the context of the weak dollar cycle and the reconstruction of the global industrial chain, Hong Kong stocks are becoming a "value discovery platform" connecting China's core assets with international capital, and a drama of asset revaluation around "China opportunities" has already begun.